Peroxisome Proliferator-Activated Receptor Gamma Agonists in Kidney Disease – Future Promise, Present Fears

Publisher： Karger

E-ISSN： 1660-2110|112|4|c230-c241

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.112, Iss.4, 2009-06, pp. : c230-c241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pleiotropic functions of peroxisome proliferator-activated receptor γ

By Debril Marie-Bernard   Renaud Jean-Paul   Fajas Lluis   Auwerx Johan  

Journal of Molecular Medicine, Vol. 79, Iss. 1, 2001-03 ,pp. : 30-47

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-&ggr; and lipodystrophy

By Tamsma Jouke T   Rabelink Ton J  

Future Lipidology, Vol. 1, Iss. 4, 2006-08 ,pp. : 455-462

Future Medicine

Access to resources Recommend Favorite

The cross‐talk between estrogen receptor and peroxisome proliferator‐activated receptor gamma in thyroid cancer

By  

CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. : 142-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein

By Cuzzocrea Salvatore   Pisano Barbara   Dugo Laura   Ianaro Angela   Britti Domenico   Patel Nimesh   Paola Rosanna   Genovese Tiziana   Rosa Massimo   Caputi Achille   Thiemermann Christoph  

Intensive Care Medicine, Vol. 30, Iss. 5, 2004-05 ,pp. : 951-956

Springer Publishing Company

Access to resources Recommend Favorite

Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Ligand, Suppresses Bleomycin-Induced Acute Lung Injury and Fibrosis

By  

Respiration, Vol. 77, Iss. 3, 2008-10 ,pp. : 311-319

Karger

Access to resources Recommend Favorite